Resources for the Comprehensive Geriatric Assessment based
Proactive and Personalised Primary Care of the Elderly
2012 AGS Beers Criteria
2012 American Geriatrics Society Beers Criteria
Purpose : Decision aid for supporting medication review.
Admin time : Highly operator dependent - 5 mins for an expert, up to 20-30 mins
User Friendly : Low-Moderate
Administered by : GP, Physician, Community pharmacist
Content : It consists of a series of medications to avoid related to common problems in prescribing for older people generally, and in relation to particular medical conditions. Several of the medications are specific to the USA.
Author : American Geriatrics Society 2012 Beers Criteria Update Expert Panel (AGS, 2012)
Copyright : free to use
Updated Beers Criteria are regularly published online by American Geriatrics Society .
The AGS has entered into a License Agreement with Clinical Support Information Systems, LTD (CSIS), granting CSIS a 15-year exclusive license to incorporate the AGS Beers Criteria® into Medication Review Solution software. For more information, contact firstname.lastname@example.org.
Fifty-three medications or medication classes encompass the final updated 2012 AGS Beers Criteria, which are divided into three categories (Table 2, Table 3 and Table 4). Tables were constructed and organized according to major therapeutic classes and organ systems.
Table 2 shows the 34 potentially inappropriate medications and classes to avoid in older adults. Notable new additions include megestrol, glyburide, and sliding-scale insulin.
Table 3 summarizes potentially inappropriate medications and classes to avoid in older adults with certain diseases and syndromes that the drugs listed can exacerbate. Notable new inclusions are thiazolidinediones or glitazones with heart failure, acetylcholinesterase inhibitors with history of syncope, and selective serotonin reuptake inhibitors with falls and fractures.
Table 4 lists medications to be used with caution in older adults. Fourteen medications and classes were categorized. Two of these involve recently marketed antithrombotics for which early evidence suggests caution for use in adults aged 75 and older.
Table 5 is a summary of medications that were moved to another category or modified since the last update, and Table 6 and Table 7 summarize medications that were removed or added since the last update.
Table 8 includes a list of the antipsychotics included in the statements.
Table 9 is the list of anticholinergic medications to be avoided in older adults compiled from drugs rated as having strong anticholinergic properties in the Anticholinergic Risk Scale (Rudolph JL) Anticholinergic Drug Scale (Carnahan RM, 2006) and Anticholinergic Burden Scale (Boustani M, 2008).
Strengths and Limitations :
The AGS Updated Beers Criteria increase awareness of inappropriate medication use in older adults (Fick DM, 2012), as well as assist nurses (Resnick B, 2012) and interprofessional team members in medication reviews and ongoing monitoring.
Additionally, they inform prescribers and clinical decision support providers as they work to improve patient outcomes.
The AGS Updated Beers Criteria do not identify all cases of potentially inappropriate prescribing and do not address overtreatment (e.g. excessive duration of therapy), drug-drug interaction, underuse of helpful medicines, or alternatives to medications associated with adverse drug events in older adults.
This Tool is used in the Medication Review
Back To : Medication Review
The Medication Review is one of 5 sub-domains of the
Back To : Medical Assessment
The Medical Assessment is one of 8 domains of the
Comprehensive Geriatric Assessment (CGA)
Back To : Comprehensive Geriatric Assessment